Page last updated: 2024-11-04

sulfanilamide and Disease Models, Animal

sulfanilamide has been researched along with Disease Models, Animal in 5 studies

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
" The pharmacokinetics of Sulfanilamide (SA), a compound with antibacterial properties, was evaluated in a preclinical model of vascular calcification."7.85Pharmacokinetics of the antimicrobial drug Sulfanilamide is altered in a preclinical model of vascular calcification. ( Brandoni, A; Torres, AM, 2017)
" The pharmacokinetics of Sulfanilamide (SA), a compound with antibacterial properties, was evaluated in a preclinical model of vascular calcification."3.85Pharmacokinetics of the antimicrobial drug Sulfanilamide is altered in a preclinical model of vascular calcification. ( Brandoni, A; Torres, AM, 2017)
" The aim of this study was to evaluate the renal clearance of sulfanilamide (a model organic anion, preferentially eliminated by the kidneys) and other parameters of global renal function in rats with arterial calcinosis."3.72Early manifestation of nephropathy in rats with arterial calcinosis. ( Brandoni, A; Ferri, A; Quaglia, NB; Torres, AM, 2003)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Scozzafava, A2
Briganti, F1
Mincione, G1
Menabuoni, L1
Mincione, F2
Supuran, CT2
Starnotti, M1
Masini, E1
Bacciottini, L1
Scrivanti, C1
Casini, A1
Vullo, D1
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W1
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A1
Nath, A1
Brandoni, A2
Torres, AM2
Quaglia, NB1
Ferri, A1

Other Studies

5 other studies available for sulfanilamide and Disease Models, Animal

ArticleYear
Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route.
    Journal of medicinal chemistry, 1999, Sep-09, Volume: 42, Issue:18

    Topics: Administration, Topical; Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Membrane

1999
Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
    Bioorganic & medicinal chemistry letters, 2005, Sep-01, Volume: 15, Issue:17

    Topics: Animals; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Disease Models,

2005
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
Pharmacokinetics of the antimicrobial drug Sulfanilamide is altered in a preclinical model of vascular calcification.
    Clinical and experimental pharmacology & physiology, 2017, Volume: 44 Suppl 1

    Topics: Acetylation; Acetyltransferases; Animals; Anti-Bacterial Agents; Biotransformation; Cholecalciferol;

2017
Early manifestation of nephropathy in rats with arterial calcinosis.
    Renal failure, 2003, Volume: 25, Issue:3

    Topics: Animals; Aorta, Abdominal; Aortic Diseases; Blood Pressure; Calcinosis; Calcium; Cholecalciferol; Di

2003